Synopsis: Diamond Power Infrastructure is in focus, as it has secured a Letter of Intent (LOI) from Enrich Energy Pvt Ltd to supply power cables worth Rs 52.48 crore and is expected to execute the project by May 2026. The shares of this company, engaged in the...
Synopsis: Natco Pharma Ltd has exhibited a bearish pattern on its 30-minute chart, signalling potential near-term downward momentum. Natco Pharma, after a prolonged downtrend and a brief corrective uptrend, has formed an inverted flag and pole pattern on the...
Synopsis: A microcap textile stock was in the focus as the company’s board gave approval for listing its 10 crore+ equity shares on the National Stock Exchange leading to enhanced visibility among public. A microcap stock in the business of weaving and catering to...
Synopsis: Agnivesh Agarwal was involved in various ventures, including being the Chairman of Hindustan Zinc, dies of cardiac arrest after a skiing accident. Agnivesh Agarwal, 49, son of Anil Agarwal, founder and chairman of Vedanta Resources Limited, dies of cardiac...
Synopsis: Futures and Options (F&O) trading offers retail investors a chance to amplify returns through leverage and strategic flexibility, but it also carries significant risks that can turn it into a wealth trap without proper understanding and discipline....
Synopsis: How did the Murugappa Group, once a Burma-based money-lending firm, evolve into a Rs 90,000 crore conglomerate and master the art of corporate turnarounds in India? The Murugappa Group started as a banking and money-lending business in Burma (now Myanmar)...
Synopsis: Shares of a small cap firm engaged in business related to railways hits 5% upper circuit upon receiving new work from Indian Railways via its subsidiary firm- Advanced Rail Controls Private Limited. A small cap stock engaged in the business of Electrical...
Synopsis: Granules India limited’s wholly owned subsidiary company Granules Pharmaceuticals has received Tentative Approval (TA) from U.S. Food and Drug Administration (US FDA) for manufacturing process, quality standard and safety data for its Abbreviated New Drug...
Synopsis: This week, shares of 16 companies worth over ₹11,900 crore will become tradable as their shareholder lock-in periods expire. Notably, 10 of these stocks are trading below their IPO prices. A lock-in period is a fixed duration during which certain investors,...
Synopsis: Akums Drugs & Pharmaceuticals witnessed a block deal of 72.78 lakh shares (4.62% equity) worth Rs. 311.5 crore at Rs. 428 per share, highlighting strong institutional interest and boosting the stock price over 4% in today’s session. The shares of...
